About Longboard Pharmaceutical
Longboard Pharmaceutical is a company based in San Diego (United States) founded in 2020 was acquired by Lundbeck in October 2024.. Longboard Pharmaceutical has raised $56 million across 1 funding round from investors including T. Rowe Price, Lundbeck and Farallon Capital Management. The company has 50 employees as of February 29, 2024. Longboard Pharmaceutical offers products and services including GPCR Therapies. Longboard Pharmaceutical operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Harmony Biosciences, among others.
- Headquarter San Diego, United States
- Employees 50 as on 29 Feb, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Longboard Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
$-54.42 M-24as on Dec 31, 2023
-
EBITDA
$-56.76 M-27as on Dec 31, 2023
-
Total Equity Funding
$56 M (USD)
in 1 rounds
-
Latest Funding Round
$56 M (USD), Series C
Oct 28, 2020
-
Investors
T. Rowe Price
& 3 more
-
Employee Count
50
as on Feb 29, 2024
-
Acquired by
Lundbeck
(Oct 14, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Longboard Pharmaceutical
Longboard Pharmaceutical offers a comprehensive portfolio of products and services, including GPCR Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pipeline of neurological medicines targeting GPCR for rare diseases treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Longboard Pharmaceutical
Longboard Pharmaceutical has successfully raised a total of $56M through 1 strategic funding round. The most recent funding activity was a Series C round of $56 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $56.0M
-
First Round
First Round
(28 Oct 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Series C - Longboard Pharmaceutical | Valuation | Farallon Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Longboard Pharmaceutical
Longboard Pharmaceutical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include T. Rowe Price, Lundbeck and Farallon Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Late-stage life sciences investments are managed via VC and PE.
|
Founded Year | Domain | Location | |
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location | |
|
Diversified asset management services are provided to investors globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Longboard Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Longboard Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Longboard Pharmaceutical Comparisons
Competitors of Longboard Pharmaceutical
Longboard Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Harmony Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for rare neurological diseases
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Longboard Pharmaceutical
Frequently Asked Questions about Longboard Pharmaceutical
When was Longboard Pharmaceutical founded?
Longboard Pharmaceutical was founded in 2020.
Where is Longboard Pharmaceutical located?
Longboard Pharmaceutical is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Longboard Pharmaceutical?
Kevin Lind is the current CEO of Longboard Pharmaceutical.
Is Longboard Pharmaceutical a funded company?
Longboard Pharmaceutical is a funded company, having raised a total of $56M across 1 funding round to date. The company's 1st funding round was a Series C of $56M, raised on Oct 28, 2020.
How many employees does Longboard Pharmaceutical have?
As of Feb 29, 2024, the latest employee count at Longboard Pharmaceutical is 50.
What does Longboard Pharmaceutical do?
Provider of therapeutic solution for treating rare neurological diseases. The company proprietary pipeline includes LP352, which is a 5-HT2C for epileptic encephalopathies; LP143 which is a cannabinoid type 2 receptor (CB2), and LP659, which is a selective S1P receptor modulator and can be used in the treatment of Epilepsies, ALS, PD, and Multiple CNS neuroinflammatory disorders.
Who are the top competitors of Longboard Pharmaceutical?
Longboard Pharmaceutical's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Longboard Pharmaceutical offer?
Longboard Pharmaceutical offers GPCR Therapies.
Who are Longboard Pharmaceutical's investors?
Longboard Pharmaceutical has 4 investors. Key investors include T. Rowe Price, Lundbeck, Farallon Capital Management, and HBM Partners.